Telotristat Terminated Phase 2 Trials for Neuroendocrine Tumors Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04543955
Telotristat With Lutathera in Neuroendocrine Tumors